Sanjay Jain

Sanjay Jain, Ph.D. leads CMC operations at DermBiont. He has more than 25 years of experience in protein expression, process development, and scale-up for GMP production of protein therapeutics and human vaccines using a variety of production systems.

He has worked for several Biotechnology/ Pharmaceutical companies, academic and non-profit organizations, in the areas of product development, project management, and business development. Most recently, he was a technical program advisor for vaccine development at the PATH Malaria Vaccine Initiative (MVI). His focus was on CMC activities related to malaria vaccine candidates, and he served as technical lead for process development, formulation development, and GMP manufacturing of recombinant protein vaccines.

Sanjay led multiple global cross-functional project teams at different stages of product development, coordinated manufacturing activities with CMO companies, and supported several IND applications for human clinical testing of recombinant protein products. He received his Ph.D. in Microbiology from Paul Sabatier University in Toulouse, France.